年轻起病结直肠癌:缺铁性贫血与便血的的风险关联
该队列研究基于美国退伍军人健康管理局1999-2016年18-49岁人群数据,发现缺铁性贫血(IDA)患者5年年轻起病结直肠癌(YCRC)累积发生率为0.45%,无IDA者为0.05%,风险差(RD)0.39%(95%CI 0.33%-0.46%),HR 10.81(95%CI 8.15-14.33);便血患者5年YCRC累积发生率为0.33%,无便血者为0.03%,RD 0.30%(95%CI 0.26%-0.33%),HR 10.66(95%CI 8.76-12.97)。结论推荐对50岁以下无明确其他病因的IDA或便血患者应强烈考虑结肠镜检查。
要点
- 50岁以下IDA患者5年YCRC累积发生率为0.45%,显著高于无IDA者的0.05%。
- 50岁以下便血患者5年YCRC累积发生率为0.33%,显著高于无便血者的0.03%。
- IDA和便血与YCRC风险均呈强关联(HR分别为10.81和10.66)。
核心结论
- 对于50岁以下无临床确认其他病因的缺铁性贫血或便血患者,应强烈考虑进行结肠镜检查。
研究设计与样本
- 基于美国退伍军人健康管理局1999-2016年18-49岁接受医疗服务的退伍军人队列研究。
- IDA分析队列按性别、出生年份和首次VHA就诊日期4:1匹配无IDA个体与IDA个体(n=239 000)。
- 便血分析队列采用相同方法匹配(n=653 740)。
- 通过链接癌症登记和/或死因特异性死亡率数据确定 incident YCRC。
主要发现
- IDA患者5年YCRC累积发生率为0.45%,无IDA者为0.05%,风险差(RD)0.39%(95%CI 0.33%-0.46%),HR 10.81(95%CI 8.15-14.33)。
- 便血患者5年YCRC累积发生率为0.33%,无便血者为0.03%,RD 0.30%(95%CI 0.26%-0.33%),HR 10.66(95%CI 8.76-12.97)。
- IDA对比无IDA的RD在男性为0.78%(95%CI 0.64%-0.92%),女性为0.08%(95%CI 0.03%-0.13%)。
- IDA对比无IDA的RD随年龄增加,<30岁为0.14%,40-49岁为0.53%。
- 便血对比无便血的RD随年龄增加,<30岁为0.04%,40-49岁为0.43%。
关键数值与推荐
- IDA患者5年YCRC累积发生率为0.45%,无IDA者为0.05%。
- 便血患者5年YCRC累积发生率为0.33%,无便血者为0.03%。
- IDA与YCRC关联的HR为10.81(95%CI 8.15-14.33)。
- 便血与YCRC关联的HR为10.66(95%CI 8.76-12.97)。
临床怎么用
- 对50岁以下缺铁性贫血患者应强烈考虑结肠镜检查以排除YCRC。
- 对50岁以下便血患者应强烈考虑结肠镜检查以排除YCRC。
- 需注意IDA和便血患者中YCRC风险随年龄增长而增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Young-onset colorectal cancer (YCRC) incidence is rising. Scant data exist on YCRC risk after presentation with concerning symptoms such as iron-deficiency anaemia (IDA) or haematochezia. We examined the association between IDA and YCRC, and haematochezia and YCRC. DESIGN: Cohort study of US Veterans aged 18-49 years receiving Veterans Health Administration (VHA) care 1999-2016. IDA analytic cohort was created matching individuals without incident IDA to those with IDA 4:1 based on sex, birth year and first VHA visit date (n=239 000). We used this approach to also create a distinct haematochezia analytic cohort (n=653 740). Incident YCRC was ascertained via linkage to cancer registry and/or cause-specific mortality data. We computed cumulative incidence, risk difference (RD) and HRs using Cox models in each cohort. RESULTS: Five-year YCRC cumulative incidence was 0.45% among individuals with IDA versus 0.05% without IDA (RD: 0.39%, 95% CI: 0.33%-0.46%), corresponding to an HR of 10.81 (95% CI: 8.15-14.33). Comparing IDA versus no IDA, RD was 0.78% for men (95% CI: 0.64%-0.92%) and 0.08% for women (95% CI: 0.03%-0.13%), and RD increased by age from 0.14% for <30 years to 0.53% for 40-49 years. YCRC cumulative incidence was 0.33% among individuals with haematochezia versus 0.03% without haematochezia (RD: 0.30%, 95% CI: 0.26%-0.33%), corresponding to an HR of 10.66 (95% CI: 8.76-12.97). Comparing haematochezia versus no haematochezia, RD increased by age from 0.04% for <30 years to 0.43% for 40-49 years. CONCLUSION: Colonoscopy should be strongly considered in adults aged <50 years with IDA or haematochezia without a clinically confirmed alternate source.
引用
- Demb J, Liu L, Murphy CC, et al. Young-onset colorectal cancer risk among individuals with iron-deficiency anaemia and haematochezia. Gut. 2020. PMID: 33443020. doi:10.1136/gutjnl-2020-321849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。